The faculty discuss the DREAMM-7 eligibility and exclusion criteria, including the exclusion of patients refractory to daratumumab or bortezomib. They consider how well the trial population reflects ...

Ayush Srivastava is a seasoned Sub Editor at India.com (Zee Media), where he specializes in the high-octane world of global entertainment. With more than four years of experience in the media industry ...

Prakhar Srivastava covers U.S. finance, including banks, card companies, payment firms, insurers, exchanges and asset managers. He also writes on IPOs and venture capital. Previously, he worked on ...

The U.S. News Doctor Finder has compiled extensive information in each doctor's profile, including where he or she was educated and trained, which hospital he or she admits patients to, and in some ...